Unknown

Dataset Information

Lyme borreliosis in Belgium: a cost-of-illness analysis.


ABSTRACT:

Background

Lyme borreliosis (LB) is the most common tick-borne disease in Europe and North America, yet its economic burden remains largely unknown. This study aimed to estimate the economic cost associated with the different clinical manifestations of LB in Belgium.

Methods

An incidence approach and societal perspective were used to estimate the total cost-of-illness for LB in Belgium. Costs were calculated for patients with erythema migrans (EM) or disseminated/late LB, including patients who developed post-treatment Lyme disease syndrome (PTLDS). Direct medical, direct non-medical (transportation & paid help) and indirect non-medical costs (productivity losses) were included in the analysis. Ambulatory cost data were collected through a prospective cohort study from June

SUBMITTER: Geebelen L 

PROVIDER: S-EPMC9703731 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature